PMID- 10234039 OWN - NLM STAT- MEDLINE DCOM- 19990601 LR - 20231014 IS - 1529-2401 (Electronic) IS - 0270-6474 (Print) IS - 0270-6474 (Linking) VI - 19 IP - 10 DP - 1999 May 15 TI - Enhancement of locomotor activity and conditioned reward to cocaine by brain-derived neurotrophic factor. PG - 4110-22 AB - The mesolimbic dopamine (DA) system has been implicated in drug reward, locomotor sensitization, and responding for reward-related stimuli [termed conditioned reinforcers (CR)]. Here, we investigated the effect of brain-derived neurotrophic factor (BDNF), which enhances the survival and function of dopaminergic neurons, on stimulant-induced locomotor sensitization and responding for CR. In experiment 1, BDNF was infused into the nucleus accumbens (NAc) or ventral tegmental area over 2 weeks via chronically implanted minipumps (1-2.5 microgram/d), and the psychomotor stimulant effects of cocaine (5-15 mg/kg, i.p.) were studied. We found that BDNF enhanced the initial stimulant effects of cocaine and seemed to facilitate the development of sensitization to repeated cocaine doses. In experiment 2, we studied the effects of intra-NAc BDNF infusions on responding for CR. BDNF-treated rats showed twice as many CR responses compared with controls when saline was first administered. BDNF enhanced responding on the CR lever more than four times that seen in control animals after a cocaine injection (10 mg/kg, i.p.). The enhanced response to cocaine in BDNF-treated animals persisted for more than a month after the BDNF infusions had stopped, indicating long-lasting changes in the mesolimbic DA system caused by BDNF administration. In experiment 3, we examined locomotor sensitization to cocaine in heterozygous BDNF knock-out mice and found that the development of sensitization was delayed compared with wild-type littermates. These results demonstrate the profound effects of BDNF on the enhancement of both cocaine-induced locomotion and facilitation of CR and suggest a possible role for BDNF in long-term adaptations of the brain to cocaine. FAU - Horger, B A AU - Horger BA AD - Laboratory of Molecular Psychiatry, Departments of Psychiatry, Pharmacology, and Neurobiology, Yale University School of Medicine, Connecticut Mental Health Center, New Haven, Connecticut 06520, USA. FAU - Iyasere, C A AU - Iyasere CA FAU - Berhow, M T AU - Berhow MT FAU - Messer, C J AU - Messer CJ FAU - Nestler, E J AU - Nestler EJ FAU - Taylor, J R AU - Taylor JR LA - eng GR - P01 DA008227/DA/NIDA NIH HHS/United States GR - DA08227/DA/NIDA NIH HHS/United States GR - DA10160/DA/NIDA NIH HHS/United States PT - Comparative Study PT - Journal Article PT - Research Support, Non-U.S. Gov't PT - Research Support, U.S. Gov't, P.H.S. PL - United States TA - J Neurosci JT - The Journal of neuroscience : the official journal of the Society for Neuroscience JID - 8102140 RN - 0 (Brain-Derived Neurotrophic Factor) RN - 0 (Dopamine Uptake Inhibitors) RN - 0 (Nerve Growth Factors) RN - I5Y540LHVR (Cocaine) SB - IM MH - Animals MH - Brain-Derived Neurotrophic Factor/*pharmacology MH - Cocaine/*pharmacology MH - Conditioning, Operant/*drug effects MH - Dopamine Uptake Inhibitors/*pharmacology MH - Drug Synergism MH - Female MH - Infusion Pumps MH - Male MH - Mice MH - Mice, Knockout MH - Motor Activity/*drug effects MH - Nerve Growth Factors/pharmacology MH - Rats MH - Rats, Sprague-Dawley MH - *Reward PMC - PMC6782687 EDAT- 1999/05/11 00:00 MHDA- 1999/05/11 00:01 PMCR- 1999/11/15 CRDT- 1999/05/11 00:00 PHST- 1999/05/11 00:00 [pubmed] PHST- 1999/05/11 00:01 [medline] PHST- 1999/05/11 00:00 [entrez] PHST- 1999/11/15 00:00 [pmc-release] AID - 3014 [pii] AID - 10.1523/JNEUROSCI.19-10-04110.1999 [doi] PST - ppublish SO - J Neurosci. 1999 May 15;19(10):4110-22. doi: 10.1523/JNEUROSCI.19-10-04110.1999.